开放合作释新动能 海口高新区生物医药产业加快发展

Core Viewpoint - The Haikou National High-tech Industrial Development Zone aims to accelerate the development of its biopharmaceutical industry through open cooperation and platform construction, targeting a trillion-yuan biopharmaceutical industry cluster [1]. Group 1: External Cooperation - Haikou High-tech Zone is expanding its external cooperation scale, having signed the "Qiong-Hong Cooperation Memorandum" in March, establishing deep cooperation with Hong Kong Science Park in biopharmaceuticals, medical devices, and intelligent equipment [2]. - The establishment of the "Qiong-Hong Science and Technology Innovation Fund" aims to create a cross-border innovation network [2]. - The Haikou High-tech Zone is expected to achieve a biopharmaceutical industry output value exceeding 21.5 billion yuan in 2024 [2]. Group 2: Domestic Collaboration - The Haikou High-tech Zone has gathered over 90% of the province's pharmaceutical companies and is exploring cooperation with the Boao Lecheng International Medical Tourism Pilot Zone to form a "Lecheng Research + Haikou Production" model [3][4]. - This model facilitates the entire chain of overseas innovative drugs and medical devices for research and production in Hainan [4]. - The Haikou High-tech Zone is continuously promoting cooperation with Boao Lecheng to attract more international advanced medical devices [4]. Group 3: Inter-Provincial Linkage - The Haikou High-tech Zone has undertaken several cooperative projects with Guangdong, Hubei, and Shanghai, establishing cross-regional industrial, innovation, funding, and talent chains [5]. - The Guangdong-Hainan Advanced Manufacturing Cooperation Industrial Park has introduced 361 enterprises and 49 projects with a total investment of 11.9 billion yuan as of April this year [5][6]. - The Haikou Bio-City project, invested by Wuhan East Lake High-tech Group, represents a significant collaboration project in Hubei-Hainan cooperation [6].